All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Johnson & Johnson, the parent company of Ethicon Endo-Surgery, LLC, reported an improper authentication vulnerability in the Ethicon Endo-Surgery Generator Gen11. EthiconEndo-Surgery, LLC has produced updates that mitigate this vulnerability in the affected product.
The following versions of the Ethicon Endo-Surgery Generator Gen11 are affected:
- Ethicon Endo-Surgery Generator Gen11, all versions released before November 29, 2017.
Impact to individual organizations depends on many factors that are unique to each organization. ICS-CERT recommends that organizations evaluate the impact of this vulnerability based on their operational environment and specific clinical usage.
Ethicon Endo-Surgery, LLC is a subsidiary of Johnson & Johnson and is a U.S.-based company that maintains offices in several countries around the world.
The Ethicon Endo-Surgery Generator Gen11 is deployed across the Healthcare and Public Health sector. This product is marketed globally.
The security authentication mechanism used between the Ethicon Endo-Surgery Generator Gen11 and single-patient use products can be bypassed, allowing for unauthorized devices to be connected to the generator, which could result in a loss of integrity or availability.
This vulnerability cannot be exploited remotely.
EXISTENCE OF EXPLOIT
No known public exploits specifically target this vulnerability.
An attacker with high skill would be able to exploit this vulnerability.
Ethicon Endo-Surgery, LLC has contacted users and initiated a field cybersecurity update to address the vulnerability in the Ethicon Endo-Surgery Generator Gen11. The update was made available on November 29, 2017. Users with questions regarding the vulnerability or the product update are advised to contact their Ethicon Endo-Surgery, LLC sales representative or Ethicon Customer Support Center at 1-877-ETHICON.
- a. CWE-287: Improper Authentication, http://cwe.mitre.org/data/definitions/287.html, web site last accessed November 28, 2017.
- b. NVD, http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2017-14018, NIST uses this advisory to create the CVE web site report. This web site will be active sometime after publication of this advisory.
- c. CVSS Calculator, https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:L, web site last accessed November 28, 2017.
For any questions related to this report, please contact the CISA at:
Toll Free: 1-888-282-0870
CISA continuously strives to improve its products and services. You can help by choosing one of the links below to provide feedback about this product.
Please share your thoughts.
We recently updated our anonymous product survey; we'd welcome your feedback.